HC
IBB icon

Hurley Capital’s iShares Biotechnology ETF IBB Stock Holding History

Hurley Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.2K Sell
290
-51
-15% -$8.77K 0.03% 177
2026
Q1 		$57.6K Hold
341
– – 0.03% 165
2025
Q4 		$57.5K Hold
341
– – 0.03% 163
2025
Q3 		$49.2K Buy
341
+1
+0.3% +$136 0.03% 196
2025
Q2 		$43.1K Sell
340
-1
-0.3% -$123 0.03% 168
2025
Q1 		$43.6K Sell
341
-99
-23% -$13.4K 0.03% 185
2024
Q4 		$59K Buy
+440
New +$61.9K 0.05% 133

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Hurley Capital's IBB Position: Q2 2026 in Review

Hurley Capital reduced its iShares Biotechnology ETF (IBB) stake by 15% in Q2 2026, selling an estimated $8.77K and leaving 290 shares worth $55.2K. The position accounts for 0.03% of the portfolio, ranked #177.

Hurley Capital first reported a position in IBB in Q4 2024 and has held it in 7 quarters since. The position peaked at $59K in Q4 2024. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Hurley Capital held 290 shares of iShares Biotechnology ETF worth $55.2K as of Q2 2026.
  • Hurley Capital sold 51 iShares Biotechnology ETF shares in Q2 2026, an estimated $8.77K.
  • iShares Biotechnology ETF made up 0.03% of Hurley Capital's portfolio in Q2 2026, its #177 holding.
  • Hurley Capital first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
  • Hurley Capital's iShares Biotechnology ETF position peaked at $59K in Q4 2024.
  • 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.